Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
In Q4 2025, the Riverwater Small Cap Strategy underperformed the Russell 2000 due to stock selection and factor headwinds, as lower-quality factors (such as high short interest and negative FCF) outperformed. Energy, IT, and...
— Nathan Fredrick, CFA
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on BioHarvest Sciences Inc.
No other institutional pitches found for this ticker yet.